Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Pain Symptom Manage. 2014 Apr 15;48(5):934–943. doi: 10.1016/j.jpainsymman.2014.02.002

Perceived Discrimination in Health Care is Associated with a Greater Burden of Pain in Sickle Cell Disease

Carlton Haywood Jr 1, Marie Diener-West 1, John Strouse 1, C Patrick Carroll 1, Shawn Bediako 1, Sophie Lanzkron 1, Jennifer Haythornthwaite 1, Gladys Onojobi 1, Mary Catherine Beach 1, for the IMPORT Investigators
PMCID: PMC4198520  NIHMSID: NIHMS586263  PMID: 24742787

Abstract

Context

Perceived discriminatory experiences in society have been associated with a higher burden of pain among some minority patient populations.

Objectives

To describe the extent to which patients with sickle cell disease (SCD) perceive discrimination from health care providers, and to examine the association of these experiences with the burden of chronic SCD pain.

Methods

Cross-sectional analysis of data collected at baseline of a prospective cohort study of SCD patient experiences of care (n = 291). Perceived race-based and disease-based discrimination from health care providers were measured using subscales adapted from the Interpersonal Processes of Care Survey. Discrimination scores were examined for their association with patient characteristics and measures of pain burden using descriptive, bivariate, and multivariate analytic techniques.

Results

Respondents reported a greater burden of race-based discrimination from health care providers than has been previously reported by African Americans, and they reported a greater amount of disease-based versus race-based discrimination. While age and having difficulty persuading providers about pain were the only patient characteristics independently associated with race-based discrimination, older age, greater emergency room utilization, having difficulty persuading providers about pain, daily chronic pain, fewer “good days” during a week, and a higher severity of pain on their “good days” were independently associated with greater disease-based discrimination.

Conclusion

Perceived disease-based, but not race-based, discrimination was found to be associated with a greater range of self-reported pain among patients with SCD. If causal, this finding could signal an important new approach to mitigating the burden of pain experienced by persons with SCD.

Keywords: Discrimination, patient-provider communication, health care quality, sickle cell disease, chronic pain

Introduction

Racial and ethnic disparities in the burden of pain and in the quality of pain treatment are a significant public health problem in the U.S. 1 A full understanding of the causes of these disparities is required for their effective mitigation. Racial and ethnic discrimination is hypothesized to play an important role in the development and maintenance of health disparities. 2 Individual perceptions of experiences with racial discrimination have been associated with a number of adverse health behaviors and outcomes, including worse physical and mental health. 3 A growing body of research has begun to explore the impact of racial discrimination as a contributing factor to the higher burden of pain experienced by racial and ethnic minorities. In one study, Edwards found that the lifetime experience of racial discrimination was the strongest predictor of the report of back pain among a sample of African Americans, even after accounting for a number of demographic, physical, and mental health-related factors. 4 Similarly, Burgess et al. found that perceived racial discrimination was associated with greater bodily pain among a sample of older African American men. 5 While these studies suggest an important potential cause of the high burden of pain typically experienced by African Americans, their design raises questions about generalizability to other African American patient populations. Additionally, both prior studies examined patient experiences of racial discrimination from a wide array of potential sources in society (e.g., school, employment, daily experiences, etc.) but failed to examine discrimination from health care providers. The extent to which perceived discrimination is experienced in health care is an important area of inquiry since it is within this context that health care organizations and health policy-makers might exert their greatest level of influence in ameliorating the health effects of discrimination.

The current study seeks to address these two important gaps in our knowledge by examining perceived discrimination in health care among patients with sickle cell disease (SCD). In the U.S., African Americans have the greatest incidence of SCD at 1 per every 400 African American births. 6 The disease has a significant impact on the health of the affected individual as it is the cause of early mortality and a great degree of morbidity, including frequent episodes of severe acute pain and a high burden of chronic pain. 7, 8

The characteristics of SCD, unfortunately, make it an ideal patient population for the study of the relationship between discrimination and pain. Many health care providers have been shown to possess negative attitudes about SCD patients that serve as significant barriers to the delivery of appropriate pain management in SCD. 915 These attitudes contribute to many problems in the interpersonal quality of care delivered to SCD patients.1619 Nevertheless, the extent to which SCD patients perceive discrimination from health care providers, and the extent to which this perceived discrimination is independently associated with the burden of SCD pain, is not known. The aims of the current study were twofold: 1) To describe the extent to which patients with SCD perceive discrimination from health care providers, and 2) To examine the association between perceived discrimination and the burden of chronic SCD pain.

Methods

Study Design, Subjects and Setting

Our study was conducted using data collected as part of the Improving Patient Outcomes with Respect and Trust (IMPORT) study. The IMPORT study is a federally funded observational cohort study of SCD patient experiences with health care taking place at two academic medical centers in the Baltimore/Washington D.C. metro area.

Eligibility criteria for the IMPORT study were: 1) age 15 years or older, 2) diagnosed with any of the following sickle hemoglobinopathies: HbSS, HbSC, Hb SB-thalassemia or Hb SS/a-thalassemia, 3) no reported plans to move in the next three years, and 4) expressed willingness to adhere to study procedures. Research assistants recruited eligible patients from waiting rooms of adult and pediatric SCD clinics at the two study sites, and all study subjects provided written informed consent. The Institutional Review Boards at both the Johns Hopkins Medical Institutions and Howard University Hospital approved all study procedures.

Data Collection Procedures

Participating patients completed a comprehensive baseline questionnaire administered by an audio computer-assisted self-interview (ACASI) system. Questions were read to the patient through a headset and they answered using touch-screen technology at a private computer station. We collected data on the patient’s perceptions of the previous quality of their health care experiences, basic demographic information, health status, clinical complications, and psychosocial characteristics. The specific measures collected and used for the current analysis are as follows:

Dependent Variables: Perceived Discrimination from Health care Providers

Our primary outcome was SCD patients’ perceptions of discrimination from health care providers. We examined two different types of discrimination as potentially perceived by patients from their providers. First, we assessed patient perceptions of discrimination on the basis of their race or ethnicity using the “Discrimination due to Race/Ethnicity” subscale from the previously validated “Interpersonal Process of Care Survey”. 20, 21 The race/ethnicity discrimination subscale is a two-item measure which asked the following: “The following questions are about the personal interactions between you and your doctor(s) over the past 12 months: 1) How often did doctors pay less attention to you because of your race or ethnicity?; and 2) How often did you feel discriminated against by doctors because of your race or ethnicity?” Responses for both are rated on a 5-point scale ranging from (1 “never”) to (5 “always”). Subscale scores for an individual were created by taking the mean of their responses to both items, with higher scores indicating a greater amount of perceived discrimination due to race/ethnicity. This subscale was found to have acceptable internal consistency in prior studies (Cronbach’s alpha = 0.79), and in our current study sample (Cronbach’s alpha = 0.72), and prior studies reported a mean (SD) score of 1.35 (0.77) out of 5 among African American respondents. 21

We adapted the race/ethnicity discrimination measure to assess perceived discrimination due to the patient having SCD (i.e., disease-based discrimination). We substituted the phrase “because of your sickle cell disease” for the phrase “because of your race or ethnicity”. This new disease-based discrimination measure had a Cronbach’s alpha of 0.87 in the current study sample.

Independent Variables: Potential Correlates of Perceived Discrimination

We examined a number of patient characteristics as potential correlates of SCD patients’ perceptions of discrimination from health care providers. Demographic characteristics consisted of patient age, sex, and education (high school or less, some college, college grad and beyond). We asked each respondent to provide an assessment of their general health status (poor/fair, good, very good/excellent), and their self-reported annual emergency department visits for pain (none, 1–2, 3–5, 6–10, 10+). We examined one aspect of the quality of the patient’s previous experiences with health care using a single-item that asked the patient if they had ever experienced difficulty in persuading health care providers about their pain (yes/no). 22 Respondents were asked to assess the burden of their chronic SCD pain using three different, single-item measures: whether or not they experience daily chronic pain (yes/no), the number of “good days” the patient experiences each week (0 to 7, with a higher score equaling a lower burden of pain during a typical week), and their self-reported level of pain on their “good days” (0 to 10, with higher scores equaling more severe pain on their “good days”).

Statistical Analyses

We used basic descriptive statistics to describe our sample’s levels of perceived discrimination and their personal characteristics. Paired t-tests were used to compare the reported burden of race-based discrimination to the reported burden of disease-based discrimination among the respondents, and one-sample t-tests were used to compare the report of race-based discrimination in the sample to scores on this measure reported in prior studies. 21 We used Pearson correlations to assess the bivariate associations among both measures of discrimination and the continuous patient characteristics. Because our two measures of discrimination were hypothesized, and later shown empirically, to be correlated, we accounted for the correlation between them by using one-way multivariate analysis of variance (MANOVA) to examine the association between both constructs taken together and our categorical patient characteristics. Wilks’ Lambda statistic was the multivariate test used to assess statistical significance. Characteristics found to be significantly associated with discrimination at the bivariate level were included in multivariate multiple regression models. These models were constructed in order to determine which (if not both) specific measure of discrimination was associated with patient characteristics, to assess the independence of the association after adjustment for other, potentially confounding, patient characteristics, and to compare the magnitude of any observed associations between both measures of discrimination. Because the association of pain with discrimination was of particular interest, and because of collinearity observed among the pain burden measures (having daily chronic pain, the number of “good days”, and the level of pain on the “good days”) only one of the pain burden measures was chosen for inclusion in the regression models. However, we conducted sensitivity analyses with each measure to assess how, if at all, the results would change with the use of a different measure of pain burden. A p-value of ≤ 0.05 was the threshold used to determine statistical significance in both the bivariate and multivariable analyses. All analyses were conducted using the Stata 13.0 statistical software package. 23

Results

Characteristics of the Sample

Two hundred ninety-one (291) individuals participated in the IMPORT study, and 97% of them reported their race as Black or African American. The characteristics of the study sample and distribution of the variables assessed for the current study are described fully in Table 1. The average age of the respondents was 34.5 years, and slightly more than half of the respondents were female. Fifty-four percent of the respondents reported having daily chronic pain, the median number of “good days” in a typical week reported by the patients was 4, and the median reported pain level on those “good days” was 2 out of 10.

Table 1.

IMPORT Sample Characteristics

Age (years), mean(sd) 34.5 (12.5)
Sex, n (%)
 Male 134 46.0
 Female 157 54.0
Education,
 HS or less 185 64.9
 Some College 45 15.8
 College Grad & more 55 19.3
General Health Status,
 Poor/Fair 111 38.4
 Good 123 42.6
 Very Good/Excellent 55 19.0
Annual Visits to Emergency Room/Infusion Center
 None 47 16.3
 1 to 2 93 32.2
 3 to 5 78 27.0
 6 to 10 42 14.5
 More than 10 29 10.0
Difficulty persuading providers about pain
 No 177 61.0
 Yes 113 39.0
Daily chronic pain
 No 132 45.7
 Yes 157 54.3
# of “Good” Pain Days (range 1–7), median(IQR) 4 (3, 6)
Pain level on “Good” Days (range 0–10), median(IQR) 2 (0, 4)

The Burden and Correlates of Perceived Discrimination

The mean (SD) score on the race/ethnicity discrimination subscale reported by this SCD sample of 1.6 (0.89) was significantly higher than the average scores of 1.35 and 1.23 observed on this measure in a comparison sample of African Americans and an all-race comparison sample, respectively (p < 0.0001), suggesting a greater level of perceived race-based discrimination among the SCD sample. The SCD sample reported an even higher level of disease-based discrimination, with a mean (SD) score of 2.1 (1.17) on the disease-based discrimination measure, which is statistically significantly higher than the observed race-based discrimination score reported by the sample (p < 0.0001).

Table 2 illustrates the bivariate correlations between the discrimination measures, as well as their correlations with the continuous patient characteristics of age and the measures of pain burden. As hypothesized, a significant and moderate-sized correlation between the two measures of discrimination was observed (r = 0.51, p < 0.001). Race-based discrimination was further observed to have a small, but significant, correlation with age (r = 0.124, p < 0.05), as well as a small but significant inverse correlation with the number of reported “good days” (r = −0.162, p < 0.01), suggesting that greater perceived discrimination was associated with fewer “good days” in a typical week. Compared to race-based discrimination, disease-based discrimination had a stronger inverse correlation with the reported number of “good days” (r = −0.266, p < 0.001), and disease-based discrimination also had a significant correlation with the reported level of pain observed on “good days” (r = 0.247, p < 0.001), suggesting that greater disease-based discrimination was associated with a more severe level of pain on the “good days”.

Table 2.

Pearson Correlations Among Perceived Discrimination, Patient Age, and Pain Burden

1 2 3 4 5
1. Race Discrimination Score ---
2. Disease Discrimination Score 0.507*** ---
3. Age 0.124* 0.0845 ---
4. # of “Good” Pain Days −0.162** −0.266*** −0.0673 ---
5. Pain on “Good” Days 0.0980 0.247*** 0.123* −0.472*** ---
*

p < 0.05,

**

p < 0.01,

***

p < 0.001

Column numbering corresponds to the matching row number. For example, Column #1 is “Race Discrimination Score”; Column #2 is “Disease Discrimination Score”; and etc.

- The individual Pearson correlations represent the magnitude of the linear association between the variables depicted at the intersection of each column/row pair. For example, the Pearson correlation between Race discrimination scores and disease discrimination scores is 0.507, which is significant at p<0.001.

Table 3 presents the association of the discrimination measures with the categorical patient characteristics. The results of the MANOVA analyses suggested that, taken together, the measures of discrimination were associated with greater emergency room utilization, having difficulty persuading providers about pain, and experiencing daily chronic pain. However, the multivariate multiple regression models (Table 4) showed an interesting pattern of associations after considering the measures of discrimination separately. In the regression models, only age and having difficulty persuading health care providers about pain remained independently associated with race-based discrimination after adjustment for emergency room utilization and experiencing daily chronic pain. In total, those patient characteristics explained about 9% of the variability in race-based discrimination scores. In contrast, age, emergency room utilization, difficulty persuading providers about pain, and having daily chronic pain were all independently associated with disease-based discrimination, and these variables explained 23% of the variability in disease-based discrimination scores overall. Furthermore, the difference in average discrimination score between patients having difficulty versus no difficulty in persuading providers about pain was larger for perceptions of disease-based discrimination (0.71, 95% CI (0.45 to 0.98) than race-based discrimination (0.45, 95% CI (0.22 to 0.67). Sensitivity analyses were conducted to determine whether the choice of measure of pain burden affected the results. Models using the number of “good days” or the pain level on the “good days” instead of the report of having daily chronic pain led to the same results and conclusions, with each model explaining about 23% of the variability in disease-based discrimination.

Table 3.

Perceived Discrimination by Patient Characteristics

Perceived Discrimination Score p-value1
Race-based Disease-based
Mean (SD) Mean(SD)
Overall 1.6(0.89) 2.1(1.17)
Sex 0.219
 Male 1.6(0.90) 2.0(1.16)
 Female 1.6(0.89) 2.1(1.17)
Education 0.264
 HS or less 1.6(0.89) 2.0(1.18)
 Some College 1.6(0.98) 2.3(1.19)
 College Grad + 1.6(0.85) 1.9(1.00)
General Health Status 0.201
 Poor/Fair 1.6(0.93) 2.2(1.18)
 Good 1.6(0.85) 2.0(1.09)
 VeryGood/Excellent 1.6(0.93) 1.8(1.20)
Emergency Room/Infusion Center Annual Visits <0.0001
 None 1.5(0.89) 1.5(0.95)
 1 to 2 1.6(0.84) 1.9(1.04)
 3 to 5 1.6(0.97) 2.1(1.12)
 6 to 10 1.7(0.96) 2.5(1.15)
More than 10 1.5(0.78) 2.8(1.34)
Difficulty Persuading Providers about Pain <0.0001
 No 1.4(0.78) 1.7(1.04)
 Yes 1.9(1.00) 2.6(1.17)
Daily Chronic Pain <0.0001
 No 1.4(0.76) 1.7(0.92)
 Yes 1.7(0.98) 2.4(1.27)
1

Joint test of group differences in discrimination means by MANOVA (Wilks’ Lambda)

Table 4.

Multivariate Multiple Regression Results

Estimated Average Change in Race-Discrimination Score [95% CI] Estimated Average Change in Disease-Discrimination Score [95% CI]
Age (years) 0.01* [0.00,0.02] 0.01* [0.00,0.02]
ED Utilization
 None Reference Reference
 1 to 2 −0.05 [−0.37,0.27] 0.29 [−0.10,0.67]
 3 to 5 −0.04 [−0.37,0.30] 0.41* [0.01,0.81]
 6 to 10 0.01 [−0.38,0.41] 0.66** [0.20,1.13]
 More than 10 −0.24 [−0.69,0.21] 0.94*** [0.41,1.48]
Difficulty Persuading – Yes vs. No 0.45*** [0.22,0.67] 0.71*** [0.45,0.98]
Chronic Pain – Yes vs. No 0.15 [−0.07,0.37] 0.27* [0.00,0.53]

N 276 276
R2 0.09 0.23
*

p < 0.05,

**

p < 0.01,

***

p < 0.001

Discussion

Research examining the prevalence of discrimination in health care is in great need, 24 as is work to replicate prior studies that have found associations between discrimination and pain. Using data collected from a large cohort of mostly adult patients with SCD in the U.S., we describe the burden of discrimination as perceived by these patients, and we find compelling differences between the association of various patient characteristics, the burden of pain, and perceptions of disease-based, as opposed to race-based, discrimination.

The SCD patients reported a relatively low burden of perceived race-based discrimination from health care providers. The mean score of 1.6 on the race-based discrimination measure used in this study suggests an average burden of race/ethnicity based discrimination from providers that falls between “never” and “rarely” using the instrument’s interpretive scale. Nevertheless, this report of discrimination, while low in absolute magnitude, suggests a significantly greater burden of perceived race-based discrimination from health care providers compared to that perceived by other groups of patients of all-races, as well as other groups of African American patients specifically, when using this same measure. 21 Both findings seem reasonable and consistent with prior knowledge. Systematic reviews of the problem of discrimination and its impact on health have found that patients tend to report relatively low levels of perceived discrimination when reporting on or thinking about their own individual experiences, but they report greater levels of perceived discrimination when asked to report on the experiences of other members from their group or community. 24 This might explain the low burden of perceived race-based discrimination found in the current study as we asked our respondents to report on their own individual experiences with doctors. At the same time, SCD is a condition with a history (in the U.S.) that is inextricably bound with notions of “African American race” that continues to this day. 25, 26 Furthermore, studies of SCD patients and health care providers have found that race is often thought by members of both groups to impact the quality of the care delivered to SCD patients. 27, 28 Therefore, it is not surprising that patients with SCD might perceive a higher level of race-based discrimination from health care providers than other groups of African American patients, as was found here.

Our SCD sample reported a greater level of discrimination from health care providers on the basis of their having SCD than due to their race or ethnicity, and many patient-characteristics were found to be independently associated with disease-based discrimination. Perceptions of disease-based, but not race-based, discrimination from health care providers were found to be independently associated with three different measures of the burden of SCD pain. Patients reporting having daily chronic pain, reporting fewer “good days” during a typical week, and reporting more severe pain on their “good days” also reported greater levels of perceived disease-based discrimination from their health care providers. This contributes to the literature on discrimination in health care by suggesting that discrimination from health care providers can have a similar impact on the experience of pain among minority populations as has been found by studies examining general experiences of discrimination in day-to-day life and their associations with pain. 4, 5 The exact mechanisms by which experiences of discrimination may affect the experience of pain are unclear. Discrimination outside of the health care system is hypothesized to lead to chronic stress, and that chronic stress may lower one’s pain sensitivity or ability to cope with pain. 2932 Our results raise the question as to whether a similar mechanism may be in place for discrimination experienced specifically within the health care setting. Repeated interactions with the health care system might lead to repeated experiences of disease-based discrimination, which in turn leads to chronic stress as experienced by the patient, and thus affects their sensitivity to, and ability to cope with, the tissue damage caused by SCD that can lead to chronic pain. The fact that disease-based, but not race-based, discrimination was found to be associated with chronic pain, independent of health care utilization, suggests that SCD patients make important distinctions between, or differentially attribute, discriminatory behaviors from health care providers and whether these behaviors are due to the patient’s race/ethnicity or their disease.

Both disease-based and race-based discrimination were found to be independently associated with having difficulty persuading health care providers about pain, though the relationship was observed to be greater in magnitude for perceptions of disease-based discrimination. Additionally, disease-based, but not race-based, discrimination was also found to be independently associated with greater emergency room utilization for pain. The negative attitudes that many health care providers have towards patients with SCD are known to be major problems and barriers to the delivery of appropriate pain management for these patients. 11, 1315 The attitudes of health care providers towards SCD patients have been shown to be associated with various characteristics of the SCD patients, with providers exhibiting more negative attitudes towards SCD patients with greater hospital utilization, and for patients that have had documented disputes with staff regarding pain or analgesia. 9 The findings of our study exactly mirror these prior findings, but from the patient’s perspective. Our findings suggest that patients who have disputes with health care providers regarding their pain attribute the difficulty to both their race/ethnic status and their status as having SCD, with their status as having SCD perhaps receiving greater attribution. Our findings also suggest that SCD patients are accurately able to pick up on the attitudes exhibited by health care providers, thus validating patient reports of the problematic experiences and poor interpersonal interactions they tend to have with providers when seeking treatment for their pain.

Some limitations must be taken into account when interpreting our findings. The cross-sectional nature of our study makes it impossible to make definitive statements regarding the causal directionality of the relationships we observed between perceived disease-based discrimination and the burden of chronic SCD pain. It is possible that SCD patients with a higher burden of chronic pain are less satisfied with the care they receive from health care providers overall, and thus more likely to perceive certain communication styles or behaviors exhibited by providers as discriminatory in nature. It is also possible that medical providers discriminate against patients with frequent or chronic pain. Future research using prospective designs is required to help disentangle the directionality of these relationships. The measures of pain burden used in the current study were designed to assess chronic SCD pain. Future studies of the relationship between discrimination and pain in SCD should include measures of acute SCD pain in order to determine if similar findings will result. If so, this would further clarify and provide greater evidence for a causal relationship between discrimination and pain. Our results suggest that SCD patients make important distinctions between race-based and disease-based discrimination. However, the nature of the measurement of both types of discrimination does not allow us to understand how the patients make distinctions between the two constructs. Furthermore, the disease-based discrimination measure used in the current study is a new measure and has not been previously validated. Nevertheless, the relationships between this new measure and other variables observed in this study provide preliminary evidence in support of its construct validity. Finally, our data were collected from a regional cohort of SCD patients in the U.S., so the extent to which these findings generalize to other SCD patients is unknown. Nevertheless, our findings of the association between perceived discrimination and pain do replicate, in part, the few prior studies examining this relationship, thus adding more evidence in support of an important role of perceived discrimination in the experience of pain.

Despite these limitations, we believe that our results provide important contributions to the literatures on discrimination in health care and discrimination as a significant cause of the greater burden of pain experienced by minorities. If the relationship between experiences of disease-based discrimination from health care providers and a greater burden of pain among SCD patients is ultimately found to be causal, this then becomes an important new area through which the burden of SCD pain may be mitigated, which is needed for a condition that has historically seen relatively few advances in the treatment of pain.

Acknowledgments

This study was funded by a grant from the National, Heart, Lung and Blood Institute (NHLBI) (#1R01HL088511-01). Dr. Haywood’s effort was funded by a Career Development Award from the NHLBI (#1K01HL108832-01). Dr. Lanzkron’s effort was funded by a Career Development Award from the NHLBI (#K23HL083089). Dr. Bediako’s effort was funded by a Career Development Award from the NHLBI (5K07HL108742-03). The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.

The authors thank all members and participants of the IMPORT study for their time and generous contributions. The full list of IMPORT investigators includes the authors, as well as the following individuals – Johns Hopkins Investigators: Tanita Woodson, Jordan Wilks, Benjamin Ajiboye, Nina Shah; Howard University Investigators: Abiodun Akintilo, Margaret Fadojutimi-Akinsiku, Patricia Oneal, Adriana Medina, Seyed Mehdi Nouraie, John Kwagyan, Kemi Owoyemi, and Ronke Ajala.

Study data were collected and managed using REDCap electronic data capture tools hosted at Johns Hopkins University. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources.

Footnotes

Disclosures

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All authors declare that they have no known conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4:277–294. doi: 10.1046/j.1526-4637.2003.03034.x. [DOI] [PubMed] [Google Scholar]
  • 2.Smedley BD, Stith AY, Nelson AR Institute of Medicine. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment : Confronting racial and ethnic disparities in health care. Washington, DC: National Academy Press; 2003. [PubMed] [Google Scholar]
  • 3.Shavers VL, Shavers BS. Racism and health inequity among americans. J Natl Med Assoc. 2006;98:386–396. [PMC free article] [PubMed] [Google Scholar]
  • 4.Edwards RR. The association of perceived discrimination with low back pain. J Behav Med. 2008;31:379–389. doi: 10.1007/s10865-008-9160-9. [DOI] [PubMed] [Google Scholar]
  • 5.Burgess DJ, Grill J, Noorbaloochi S, et al. The effect of perceived racial discrimination on bodily pain among older African American men. Pain Med. 2009;10:1341–1352. doi: 10.1111/j.1526-4637.2009.00742.x. [DOI] [PubMed] [Google Scholar]
  • 6.Kaye CI, Accurso F, et al. Committee on Genetics. Newborn screening fact sheets. Pediatrics. 2006;118:e934–63. doi: 10.1542/peds.2006-1783. [DOI] [PubMed] [Google Scholar]
  • 7.Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. rates and risk factors. N Engl J Med. 1991;325:11–16. doi: 10.1056/NEJM199107043250103. [DOI] [PubMed] [Google Scholar]
  • 8.Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148:94–101. doi: 10.7326/0003-4819-148-2-200801150-00004. [DOI] [PubMed] [Google Scholar]
  • 9.Ratanawongsa N, Haywood C, Jr, Bediako SM, et al. Health care provider attitudes toward patients with acute vaso-occlusive crisis due to sickle cell disease: development of a scale. Patient Educ Couns. 2009;76:272–278. doi: 10.1016/j.pec.2009.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Haywood C, Jr, Lanzkron S, Hughes MT, et al. A video-intervention to improve clinician attitudes toward patients with sickle cell disease: the results of a randomized experiment. J Gen Intern Med. 2011;26:518–523. doi: 10.1007/s11606-010-1605-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Glassberg JA, Tanabe P, Chow A, et al. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Ann Emerg Med. 2013;62:293–302. doi: 10.1016/j.annemergmed.2013.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Glassberg J, Tanabe P, Richardson L, Debaun M. Among emergency physicians, use of the term “sickler” is associated with negative attitudes toward people with sickle cell disease. Am J Hematol. 2013;88:532–533. doi: 10.1002/ajh.23441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Haywood C, Jr, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101:1022–1033. doi: 10.1016/s0027-9684(15)31069-5. [DOI] [PubMed] [Google Scholar]
  • 14.Elander J, Midence K. A review of evidence about factors affecting quality of pain management in sickle cell disease. Clin J Pain. 1996;12:180–193. doi: 10.1097/00002508-199609000-00006. [DOI] [PubMed] [Google Scholar]
  • 15.Wright K, Adeosum O. Barriers to effective pain management in sickle cell disease. Br J Nurs. 2009;18:158–161. doi: 10.12968/bjon.2009.18.3.39043. [DOI] [PubMed] [Google Scholar]
  • 16.Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ. 1999;318:1585–1590. doi: 10.1136/bmj.318.7198.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Elander J, Beach MC, Haywood C. Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health. 2011;16:405–421. doi: 10.1080/13557858.2011.555520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zempsky WT. Treatment of sickle cell pain: fostering trust and justice. JAMA. 2009;302:2479–2480. doi: 10.1001/jama.2009.1811. [DOI] [PubMed] [Google Scholar]
  • 19.Lattimer L, Haywood C, Jr, Lanzkron S, et al. Problematic hospital experiences among adult patients with sickle cell disease. J Health Care Poor Underserved. 2010;21:1114–1123. doi: 10.1353/hpu.2010.0940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Stewart AL, Napoles-Springer A, Perez-Stable EJ. Interpersonal processes of care in diverse populations. Milbank Q. 1999;77:305–39. 274. doi: 10.1111/1468-0009.00138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J. Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res. 2007;42:1235–1256. doi: 10.1111/j.1475-6773.2006.00637.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27:156–169. doi: 10.1016/j.jpainsymman.2003.12.001. [DOI] [PubMed] [Google Scholar]
  • 23.StataCorp. Stata statistical software: Release 13. College Station, TX: StataCorp LP; 2013. [Google Scholar]
  • 24.Shavers VL, Fagan P, Jones D, et al. The state of research on racial/ethnic discrimination in the receipt of health care. Am J Public Health. 2012;102:953–966. doi: 10.2105/AJPH.2012.300773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bediako SM, Haywood C., Jr Sickle cell disease in a “postracial” america. J Natl Med Assoc. 2009;101:1065–1066. doi: 10.1016/s0027-9684(15)31075-0. [DOI] [PubMed] [Google Scholar]
  • 26.Bediako SM, Moffitt KR. Race and social attitudes about sickle cell disease. Ethn Health. 2011;16:423–429. doi: 10.1080/13557858.2011.552712. [DOI] [PubMed] [Google Scholar]
  • 27.Telfair J, Myers J, Drezner S. Does race influence the provision of care to persons with sickle cell disease? perceptions of multidisciplinary providers. J Health Care Poor Underserved. 1998;9:184–195. doi: 10.1353/hpu.2010.0127. [DOI] [PubMed] [Google Scholar]
  • 28.Chestnut DE. Perceptions of ethnic and cultural factors in the delivery of services in the treatment of sickle cell disease. J Health Soc Policy. 1994;5:215–242. doi: 10.1300/J045v05n03_13. [DOI] [PubMed] [Google Scholar]
  • 29.Harrell JP, Hall S, Taliaferro J. Physiological responses to racism and discrimination: an assessment of the evidence. Am J Public Health. 2003;93:243–248. doi: 10.2105/ajph.93.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mays VM, Cochran SD, Barnes NW. Race, race-based discrimination, and health outcomes among African Americans. Annu Rev Psychol. 2007;58:201–225. doi: 10.1146/annurev.psych.57.102904.190212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Clark R, Anderson NB, Clark VR, Williams DR. Racism as a stressor for african americans. A biopsychosocial model. Am Psychol. 1999;54:805–816. doi: 10.1037//0003-066x.54.10.805. [DOI] [PubMed] [Google Scholar]
  • 32.Anton F. Chronic stress and pain - a plea for a concerted research program. Pain. 2009;143:163–164. doi: 10.1016/j.pain.2009.03.012. [DOI] [PubMed] [Google Scholar]

RESOURCES